Clinical Trial Update: Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP [Phase 3]

View source ↗

Summary

A Phase 3 trial in chronic lymphocytic leukemia comparing Fludarabine, Cyclophosphamide, and Rituximab versus Alemtuzumab has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Leukemia | Phase 3 | Status: COMPLETED